p62/SQSTM1 by Binding to Vitamin D Receptor Inhibits Hepatic Stellate Cell Activity, Fibrosis, and Liver Cancer.
p62/SQSTM1 by Binding to Vitamin D Receptor Inhibits Hepatic Stellate Cell Activity, Fibrosis, and Liver Cancer.
复制标题
P62/SQSTM1与维生素D受体结合抑制肝星细胞活性,纤维化和肝癌。
DOI:
10.1016/j.ccell.2016.09.004
复制
发表时间:
2016-10-10
期刊:
影响因子:
50.3
通讯作者:
Moscat J
中科院分区:
文献类型:
--
作者:
Duran A;Hernandez ED;Reina-Campos M;Castilla EA;Subramaniam S;Raghunandan S;Roberts LR;Kisseleva T;Karin M;Diaz-Meco MT;Moscat J
Hepatic stellate cells (HSC) play critical roles in liver fibrosis and hepatocellular carcinoma (HCC). Vitamin D receptor (VDR) activation in HSC inhibits liver inflammation and fibrosis. We found that p62/SQSTM1, a protein upregulated in liver parenchymal cells but downregulated in HCC-associated HSC, negatively controls HSC activation. Total body or HSC-specific p62 ablation potentiates HSC and enhances inflammation, fibrosis and HCC progression. p62 directly interacts with VDR and RXR promoting their heterodimerization, which is critical for VDR:RXR target gene recruitment. Loss of p62 in HSC impairs the repression of fibrosis and inflammation by VDR agonists. This demonstrates that p62 is a negative regulator of liver inflammation and fibrosis through its ability to promote VDR signaling in HSC, whose activation supports HCC.
登录
查看更多内容
影响因子:
50.3
作者:
Özdemir BC;Pentcheva-Hoang T;Carstens JL;Zheng X;Wu CC;Simpson TR;Laklai H;Sugimoto H;Kahlert C;Novitskiy SV;De Jesus-Acosta A;Sharma P;Heidari P;Mahmood U;Chin L;Moses HL;Weaver VM;Maitra A;Allison JP;LeBleu VS;Kalluri R
通讯作者:
Kalluri R
影响因子:
16
作者:
Duran A;Amanchy R;Linares JF;Joshi J;Abu-Baker S;Porollo A;Hansen M;Moscat J;Diaz-Meco MT
通讯作者:
Diaz-Meco MT
影响因子:
50.3
作者:
Duran, Angeles;Linares, Juan F.;Moscat, Jorge
通讯作者:
Moscat, Jorge
DOI:
10.1073/pnas.1201840109
发表时间:
2012-06-12
影响因子:
11.1
作者:
Kisseleva, Tatiana;Cong, Min;Brenner, David A.
通讯作者:
Brenner, David A.
影响因子:
64.8
作者:
Heery, DM;Kalkhoven, E;Parker, MG
通讯作者:
Parker, MG